Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by 11C-Choline PET

Article Figures & Data

TABLE 1

Preoperative Clinical and Pathologic Data for All Patients

Data are presented as number of patients, with percentages in parentheses, except for age, for which data are mean ± SD, and for PSA, for which data are median and range.

TABLE 2

Patient Details, Pelvic Lymph Node Dissection, and Uptake of ¹¹C-Choline in Lymph Node–Positive Patients

Patient no.	Age (y)	PSA (ng/mL)	Gleason sum score	Lymph node metastases	¹¹C-Choline			Treatment	Follow-up at 12 mo
Patient no.	Age (y)	PSA (ng/mL)	Gleason sum score	Lymph node metastases				Treatment	Follow-up at 12 mo	Visual uptake	SUV nodes
1	67	37	6	Obturator right	+	3.2	HORM	PSA < 0.1
2	59	12.8	7	Obturator right (micrometastasis)	−	−	XBRT + HORM	PSA = 0.3
3	61	500	6	Bilateral obturator and iliac	+++	9.1	WW	PSA = 500
4	69	22	7	Bilateral obturator	+	2.9	XBRT + HORM	PSA < 0.1
5	69	148	8	Iliac left	+	2.0	HORM	PSA = 52, relapse
6	75	58	7	Iliac left	++	4.3	HORM	PSA = 0.1
7	66	47	7	Iliac left, obturator right	+++	4.7	HORM	PSA = 5.2
8	64	35	6	Iliac/obturator left	+	1.3	HORM	PSA = 0.1
9	59	47	9	Iliac/paraaortal	++	1.9	HORM	HRPC at 10 mo
10	78	39	7	Iliac left	++	1.3	HORM	PSA = 0.76
11	70	83	7	Iliac right	+++	4.3	HORM	PSA = 15.3
12	66	108	9	Left obturator	−	−	HORM	PSA = 0.49
13	65	283	8	Bilateral iliac/aorta	++	4.6	HORM	PSA = 161, relapse
14	56	376	6	Iliac left	+++	6.7	HORM	NA
15	63	63	9	Obturator right	−	−	HORM	NA

SUV = standardized uptake value; HORM = androgen-deprivation therapy; XBRT = external-beam radiation therapy; WW = watchful waiting; HRPC = hormone-refractory prostate cancer; NA = not available.